touchPODCAST

Continuous glucose monitoring in type 2 diabetes: Overcoming barriers to optimize outcomes

touchPANEL DISCUSSION for touchENDOCRINOLOGY

Listen to a panel of experts discuss the benefits of CGM in patients with T2D, strategies to overcome the barriers to its uptake and how to best support patients in implementing CGM.

The experts

• Prof. Stewart Harris, Western University,  London, Ontario, Canada,
• Dr Anders Carlson, International Diabetes Center at Park Nicollet, Minneapolis, MN, USA,
• Prof. Shannon Idzik, University of Maryland School of Nursing, Baltimore, MD, USA
  

This touchPODCAST is for HCPs outside of the UK only.

This activity is funded by an independent medical education grant from Abbott Diabetes Care Inc. This activity is jointly provided by USF Health and touchIME.

touchIME is an EBAC® accredited provider.

For further information visit our website: 
www.touchENDOCRINOLOGY.com 

Personalizing care within the MDT for patients with early through to advanced RCC

touchFOCUS for touchONCOLOGY

Listen to Prof. Hans Hammers as he answers a series of questions on the application of prognostic markers and clinical data within the multidisciplinary team to personalize care for patients with early stage through to advanced and metastatic RCC. In addition, he responds to questions on the use of effective communication strategies and shared decision-making when managing diverse and/or underserved populations with RCC.

The expert

• Prof. Hans Hammers, UT Southwestern, Dallas, TX, USA

This touchPODCAST is for HCPs only.

This activity is funded by an independent medical education grant from MSD. This activity is jointly provided by USF Health and touchIME.

For further information visit our website: https://touchoncologyime.org/personalizing-care-multidisciplinary-team-renal-cell-carcinoma/

Selecting ART: Working with people living with HIV to find the best regimen

touchIN CONVERSATION for touchINFECTIOUS DISEASES

Listen to a conversation between Dr Christoph Boesecke and Dr Tristan Barber, two experts on HIV practising in Germany and the UK. They respond to questions submitted by the HCP audience and provide their insights on best practices for antiretroviral therapy selection for people living with HIV.

The experts

• Dr Christoph Boesecke – University of Bonn, Bonn, Germany
• Dr Tristan Barber – Royal Free London NHS Foundation Trust, London, UK

This touchPODCAST is for HCPs outside of the UK only.

This activity is funded by an independent medical educational grant from ViiV Healthcare. This activity is provided by touchIME.

For further information visit our website:

https://touchinfectiousdiseases.com/education/hiv-art-selection-shared-decision-making/

 

 

 

Thyroid eye disease: An evolving continuum of care

touchPANEL DISCUSSION for touchOPHTHALMOLOGY

Listen to a panel of leading experts discuss thyroid eye disease, including the underlying mechanisms, risk factors, symptomatology and burden of disease in affected patients, as well as the process for screening and diagnosing the disease.

The experts

• Dr Andrea Kossler, Stanford University School of Medicine, Palo Alto, CA, USA
• Dr Mario Salvi, University of Milan, Milan, Italy
• Dr Edsel Ing, University of Alberta, Edmonton and University of Toronto, Ontario, Canada

This touchPODCAST is for HCPs only. 

This activity is funded by an independent medical education grant from Horizon Therapeutics and is jointly provided by USF Health and touchIME. touchIME is an EBAC® accredited provider.

For further information visit:

https://touchophthalmologyime.org/thyroid-eye-disease-an-evolving-continuum-of-care/

Thyroid eye disease: An evolving continuum of care

touchPANEL DISCUSSION for touchENDOCRINOLOGY

Listen to a panel of leading experts discuss thyroid eye disease, including the underlying mechanisms, risk factors, symptomatology and burden of disease in affected patients, as well as the process for screening and diagnosing the disease. 

The experts

• Dr Andrea Kossler, Stanford University School of Medicine, Palo Alto, CA, USA
• Dr Mario Salvi, University of Milan, Milan, Italy
• Dr Edsel Ing, University of Alberta, Edmonton and University of Toronto, Ontario, Canada

This touchPODCAST is for HCPs only. 

This activity is funded by an independent medical education grant from Horizon Therapeutics and is jointly provided by USF Health and touchIME. touchIME is an EBAC® accredited provider.

For further information visit:

https://touchendocrinologyime.org/thyroid-eye-disease-an-evolving-continuum-of-care/

 

 

Intracranial haemorrhage related to direct oral anticoagulant medications: Latest evidence for reversal strategies

touchTALKS for touchNEUROLOGY

A thrombosis and haemostasis expert shares insights into reversal strategies for patients with direct oral anticoagulant-associated intracranial haemorrhage (DOAC-ICH), including benefits and risks of DOAC use, evidence for DOAC reversal agents and guideline-directed management of the condition. 

The expert

• Prof. Dr. med. Jan Beyer-Westendorf, University Hospital Carl Gustav Carus, Dresden, Germany

This touchPODCAST is for HCPs outside of the UK only.

This activity is funded by an independent medical education grant from AstraZeneca. This activity is jointly provided by USF Health and touchIME.

For further information visit our website: www.touchneurology.com

Intracranial haemorrhage related to direct oral anticoagulant medications: Latest evidence for reversal strategies

touchTALKS for touchCARDIO

A thrombosis and haemostasis expert shares insights into reversal strategies for patients with direct oral anticoagulant-associated intracranial haemorrhage (DOAC-ICH), including benefits and risks of DOAC use, evidence for DOAC reversal agents and guideline-directed management of the condition. 

The expert

• Prof. Dr. med. Jan Beyer-Westendorf, University Hospital Carl Gustav Carus, Dresden, Germany

This touchPODCAST is for HCPs outside of the UK only.

This activity is funded by an independent medical education grant from AstraZeneca. This activity is jointly provided by USF Health and touchIME.

For further information visit our website: www.touchCARDIO.com 

Expanding the reach of HER2 in solid tumours: A spotlight on tumour-agnostic approaches

touchFOCUS for touchONCOLOGY

 

Listen to Dr Dana Chase discuss the role of HER2 as a pan-tumour biomarker and the implications for treatment across various cancer types.

The expert

• Dr Dana Chase - UCLA Health, Los Angeles, CA, USA

 

This touchPODCAST is for HCPs only.

 

This activity is funded by an independent medical education grant from AstraZeneca. This activity is jointly provided by USF Health and touchIME. touchIME is an EBAC® accredited provider. 

 

For further information visit our website: https://touchoncologyime.org/

 

The path from detection to personalized long-term care for Fabry disease

touchEXPERT OPINIONS for touchENDOCRINOLOGY

Listen to three leading Fabry disease experts discuss early diagnosis, organ monitoring, long-term individualized care and future directions.

The experts

• Prof. Aleš Linhart, Charles University and General University Hospital, Prague, Czech Republic
• Dr Eric Wallace, University of Alabama at Birmingham School of Medicine, Birmingham, AL, USA
• Prof. William Wilcox, Emory University School of Medicine, Atlanta, GA, USA

This touchPODCAST is for healthcare professionals outside of the UK only.

This activity is funded by an independent medical education grant from Amicus Therapeutics Inc. This activity is jointly provided by USF Health and touchIME.

For further information visit our website: 

www.touchENDOCRINOLOGY.com 

 

The path from detection to personalized long-term care for Fabry disease

touchEXPERT OPINIONS for touchCARDIO

Listen to three leading Fabry disease experts discuss early diagnosis, organ monitoring, long-term individualized care and future directions.

The experts

• Prof. Aleš Linhart, Charles University and General University Hospital, Prague, Czech Republic
• Dr Eric Wallace, University of Alabama at Birmingham School of Medicine, Birmingham, AL, USA
• Prof. William Wilcox, Emory University School of Medicine, Atlanta, GA, USA

This touchPODCAST is for healthcare professionals outside of the UK only.

This activity is funded by an independent medical education grant from Amicus Therapeutics Inc. This activity is jointly provided by USF Health and touchIME.

For further information visit our website: 

www.touchCARDIO.com